- GivBux (OTCPK:GBUX) said it has entered into a letter of intent to buy distributor of biomolecular health products, VitorganAmerica.shop in a $39M deal.
- The deal will bring VitorganAmerica.shop’s supplements into the GivBux network for expanded distribution across the United States and Latin America.
